MedPath

A randomized trial of adjuvant chemotherapy in resected stage I lung adenocarcinoma with high SUV index. JNETS 1201

Phase 3
Conditions
ung cancer
Registration Number
JPRN-UMIN000007790
Lead Sponsor
Japanese Northern East Area Thoracic Surgery Study Group (JNETS-SG)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
460
Inclusion Criteria

Not provided

Exclusion Criteria

non-p-stage I lung adenocarcinoma with SUV index with 1 or more.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall survival
Secondary Outcome Measures
NameTimeMethod
Disease-free survival
© Copyright 2025. All Rights Reserved by MedPath